Targeting Immune Cell Metabolism: A Promising Therapeutic Approach for Cardiovascular Disease
Dexiang Xia,
No information about this author
Qinwen Zheng,
No information about this author
Yue Liu
No information about this author
et al.
Immunology,
Journal Year:
2025,
Volume and Issue:
unknown
Published: March 24, 2025
Cardiovascular
disease
(CVD)
is
a
leading
cause
of
morbidity
and
mortality
globally.
Recent
groundbreaking
preclinical
clinical
research
underscores
the
pivotal
role
metabolite
remodelling
in
pathology
CVD.
This
metabolic
transformation
not
only
directly
fuels
progression
CVD
but
also
profoundly
influences
immune
response
within
cardiovascular
system.
In
this
review,
we
focused
on
complex
interactions
between
alterations
responses
during
course
Furthermore,
explore
potential
therapeutic
interventions
that
could
be
developed
based
understanding
dysregulation
By
targeting
these
immunological
pathways,
novel
strategies
for
prevention
treatment
CVDs
might
to
improve
patient
outcomes
reduce
global
burden
disease.
Language: Английский
Macrophage Depletion Alleviates Immunosenescence in Diabetic Kidney by Modulating GDF-15 and Klotho
Asma S. Alonazi,
No information about this author
Rana M. Aloraini,
No information about this author
Lama M. Albulayhi
No information about this author
et al.
International Journal of Molecular Sciences,
Journal Year:
2025,
Volume and Issue:
26(9), P. 3990 - 3990
Published: April 23, 2025
Cellular
senescence
is
a
hallmark
of
aging
and
contributes
to
age-related
diseases,
including
diabetic
nephropathy
(DN).
Additionally,
macrophage-mediated
inflammation
has
been
linked
with
DKD.
Therefore,
we
investigated
the
effect
macrophage
depletion
on
kidney
cell
in
DN,
focusing
relationship
between
GDF-15
Klotho
signaling
pathways.
Wistar
albino
rats
(n
=
24)
were
divided
into
four
groups:
healthy
control,
liposomal
clodronate
(LC)-treated
healthy,
diabetic,
LC-treated
groups.
Rats
groups
intravenously
administered
LC
once
week
for
4
weeks.
Rat
models
type
2
diabetes
successfully
established
via
administration
streptozotocin
high-fat
diet,
as
evidenced
by
increased
blood
glucose
levels,
weight
body
(KW/BW)
ratio,
serum
albumin,
creatinine,
urea
damage,
oxidative
stress.
However,
LC-mediated
reduced
KW/BW
improved
parameters,
decreased
inflammatory
markers
(IL-6
TNF-α),
ameliorated
treatment
promoted
polarization
towards
anti-inflammatory
phenotype,
downregulated
expression,
upregulated
damage.
In
conclusion,
combats
modulating
GDF-15,
indicating
their
potential
novel
targets
DN
treatment.
Language: Английский